Fatal pulmonary fibrosis can occur with COVID-19

But, an expert asks, was the case due to ventilation or to a biological effect of the virus?
Reuters Health Staff writer

COVID-19 can result in fatal pulmonary fibrosis, according to a case report.

Danish doctors describe the case of a woman in her 80s admitted to hospital with COVID-19 who then developed the disease.

The patient developed severe acute respiratory distress syndrome (ARDS) during her hospitalisation and was treated with lung-protective ventilation, heavy sedation/neuromuscular blockade, prone positioning and inhaled nitric oxide, they report in the Journal of Clinical Pathology.

A CT scan on day 18 revealed large bilateral central pulmonary emboli that were treated with high-dose dalteparin.